Literature DB >> 31862753

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2020.

.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc20-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc20-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2020        PMID: 31862753     DOI: 10.2337/dc20-S010

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  124 in total

1.  Combining Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors to Target Multiple Organ Defects in Type 2 Diabetes.

Authors:  John E Anderson
Journal:  Diabetes Spectr       Date:  2020-05

Review 2.  Diabetes Complications in Racial and Ethnic Minority Populations in the USA.

Authors:  J Sonya Haw; Megha Shah; Sara Turbow; Michelle Egeolu; Guillermo Umpierrez
Journal:  Curr Diab Rep       Date:  2021-01-09       Impact factor: 4.810

Review 3.  Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?

Authors:  Matthew D Ettleson; Antonio C Bianco
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

4.  SUCCESSFUL REIMPLEMENTATION OF A VERY LOW CARBOHYDRATE KETOGENIC DIET AFTER SGLT2 INHIBITOR ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS.

Authors:  Ethan I Fieger; Kristen M Fadel; Amir H Modarres; Edmond P Wickham; Susan E Wolver
Journal:  AACE Clin Case Rep       Date:  2020-08-06

5.  2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.

Authors:  Sandeep R Das; Brendan M Everett; Kim K Birtcher; Jenifer M Brown; James L Januzzi; Rita R Kalyani; Mikhail Kosiborod; Melissa Magwire; Pamela B Morris; Joshua J Neumiller; Laurence S Sperling
Journal:  J Am Coll Cardiol       Date:  2020-08-05       Impact factor: 24.094

6.  Injection-Site Nodules Associated With Once-Weekly Subcutaneous Administration of Semaglutide.

Authors:  Elizabeth B Hearn; Justin J Sherman
Journal:  Diabetes Spectr       Date:  2021-01

Review 7.  Diabetes in People with HIV.

Authors:  Sudipa Sarkar; Todd T Brown
Journal:  Curr Diab Rep       Date:  2021-03-17       Impact factor: 4.810

Review 8.  Assessing the dyslipidemias: to fast or not to fast?

Authors:  Zareen Farukhi; Samia Mora
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2021-04-01       Impact factor: 3.243

9.  Medical assistant health coaching ("MAC") for type 2 diabetes in diverse primary care settings: A pragmatic, cluster-randomized controlled trial protocol.

Authors:  Addie L Fortmann; Athena Philis-Tsimikas; Johanna A Euyoque; Taylor L Clark; Daniela G Vital; Haley Sandoval; Julia I Bravin; Kimberly L Savin; Jennifer A Jones; Scott Roesch; Todd Gilmer; Thomas Bodenheimer; James Schultz; Linda C Gallo
Journal:  Contemp Clin Trials       Date:  2020-10-11       Impact factor: 2.226

10.  Glycemic control is associated with dyslipidemia over time in youth with type 2 diabetes: The SEARCH for diabetes in youth study.

Authors:  Ryan P Brady; Amy S Shah; Elizabeth T Jensen; Jeanette M Stafford; Ralph B D'Agostino; Lawrence M Dolan; Lisa Knight; Giuseppina Imperatore; Christine B Turley; Angela D Liese; Elaine M Urbina; Jean M Lawrence; Catherine Pihoker; Santica Marcovina; Dana Dabelea
Journal:  Pediatr Diabetes       Date:  2021-08-15       Impact factor: 4.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.